Lowest-Rated Stocks NASDAQ:SYNH Syneos Health - SYNH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Syneos Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $34.33 -0.61 (-1.75%) (As of 03/28/2023 12:00 AM ET) Add Compare Share Share Today's Range$34.13▼$35.2450-Day Range$33.32▼$40.9852-Week Range$22.89▼$85.45Volume575,910 shsAverage Volume1.73 million shsMarket Capitalization$3.54 billionP/E Ratio13.36Dividend YieldN/APrice Target$54.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Syneos Health MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside57.3% Upside$54.00 Price TargetShort InterestHealthy3.35% of Float Sold ShortDividend StrengthN/ASustainability-1.00Upright™ Environmental ScoreNews Sentiment1.08Based on 9 Articles This WeekInsider TradingN/AProj. Earnings Growth18.25%From $2.85 to $3.37 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.98 out of 5 starsMedical Sector32nd out of 1,002 stocksCommercial Physical Research Industry3rd out of 16 stocks 3.0 Analyst's Opinion Consensus RatingSyneos Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 6 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $54.00, Syneos Health has a forecasted upside of 57.3% from its current price of $34.33.Amount of Analyst CoverageSyneos Health has only been the subject of 4 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.35% of the float of Syneos Health has been sold short.Short Interest Ratio / Days to CoverSyneos Health has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Syneos Health has recently decreased by 46.57%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSyneos Health does not currently pay a dividend.Dividend GrowthSyneos Health does not have a long track record of dividend growth. Previous Next 4.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSyneos Health has received a 70.43% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is mostly driven by its "Clinical research services for physical health", "Clinical research services for mental health", and "Management consulting for medical technology industry" products. See details.Environmental SustainabilityThe Environmental Impact score for Syneos Health is -1.00. Previous Next 3.4 News and Social Media Coverage News SentimentSyneos Health has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Syneos Health this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for SYNH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows3 people have added Syneos Health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Syneos Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.34% of the stock of Syneos Health is held by insiders.Percentage Held by Institutions93.51% of the stock of Syneos Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Syneos Health are expected to grow by 18.25% in the coming year, from $2.85 to $3.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Syneos Health is 13.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.89.Price to Earnings Ratio vs. SectorThe P/E ratio of Syneos Health is 13.36, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 123.12.Price to Book Value per Share RatioSyneos Health has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Syneos Health (NASDAQ:SYNH) StockSyneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC.Read More Receive SYNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNH Stock News HeadlinesMarch 28, 2023 | americanbankingnews.comSyneos Health, Inc. (NASDAQ:SYNH) Receives Average Recommendation of "Hold" from BrokeragesMarch 27, 2023 | finance.yahoo.comSyneos Health Launches Medical Affairs Digital AmplifierMarch 29, 2023 | Investor Place Media (Ad)The "King Of Quants" sees 10X potential...Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...March 23, 2023 | finance.yahoo.comSyneos Health (SYNH) Partners With KX for Data-Driven InsightsMarch 22, 2023 | finance.yahoo.comSyneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset DevelopmentMarch 20, 2023 | finance.yahoo.comSyneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial ContinuumMarch 19, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Now Covered by Analysts at StockNews.comMarch 17, 2023 | finance.yahoo.comShould You Exit Your Position in Syneos Health (SYNH)?March 29, 2023 | Investing Daily (Ad)A 100% Win Rate In 2022…The next 10 minutes could change your life. We've recorded a special sit-down interview with a reclusive millionaire who details how he's closed out winning trade after winning trade throughout the volatility of 2022. In fact, he hasn't closed a single losing trade since 2016. Sounds impossible? It's not - and he'll prove it to you. March 15, 2023 | finance.yahoo.comSyneos Health's (SYNH) Product Launch Aids, FX Woe HurtsMarch 15, 2023 | finance.yahoo.comShould You Be Adding Syneos Health (NASDAQ:SYNH) To Your Watchlist Today?March 4, 2023 | benzinga.comSyneos Health Stock (NASDAQ:SYNH), Analyst Ratings, Price Targets, PredictionsMarch 3, 2023 | benzinga.comSyneos Health Stock (NASDAQ:SYNH), Guidance and ForecastMarch 3, 2023 | benzinga.comSyneos Health Stock (NASDAQ:SYNH), Short Interest ReportMarch 1, 2023 | msn.comSyneos Health may be worth between $40-$53 a share in a sale - analystMarch 1, 2023 | reuters.comExclusive: Syneos Health eyes sale of company as contract backlog shrinks-sourcesFebruary 28, 2023 | 247wallst.comUnusual Call Option Trade in Syneos Health Worth $130.75KFebruary 28, 2023 | finance.yahoo.comSyneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT AdoptionFebruary 28, 2023 | finance.yahoo.comSyneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT AdoptionFebruary 27, 2023 | bizjournals.comReport: Syneos Health explores sale amid life sciences consolidationFebruary 20, 2023 | finance.yahoo.comSyneos Health, Inc. (NASDAQ:SYNH) Q4 2022 Earnings Call TranscriptFebruary 18, 2023 | seekingalpha.comSyneos Health, Inc. (SYNH) Q4 2022 Earnings Call TranscriptFebruary 18, 2023 | finance.yahoo.comSyneos Health Full Year 2022 Earnings: Revenues Beat Expectations, EPS In LineFebruary 17, 2023 | finance.yahoo.comSyneos Health (SYNH) Q4 Earnings Beat Estimates, Margins DownFebruary 17, 2023 | finance.yahoo.comSyneos targets expenses, office footprint to offset revenue dropFebruary 17, 2023 | markets.businessinsider.comBarclays Keeps Their Sell Rating on Syneos Health (SYNH)February 16, 2023 | forbes.comUpdate: SYNH and RBBN, February 16See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SYNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNH Company Calendar Last Earnings2/16/2023Today3/28/2023Next Earnings (Estimated)5/05/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SYNH CUSIPN/A CIK1610950 Webwww.syneoshealth.com Phone(919) 876-9300Fax919-876-9360Employees29,395Year FoundedN/APrice Target and Rating Average Stock Price Forecast$54.00 High Stock Price Forecast$81.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+57.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$2.57 Trailing P/E Ratio13.36 Forward P/E Ratio12.05 P/E GrowthN/ANet Income$266.50 million Net Margins4.94% Pretax Margin5.83% Return on Equity13.19% Return on Assets5.40% Debt Debt-to-Equity Ratio0.76 Current Ratio1.13 Quick Ratio1.13 Sales & Book Value Annual Sales$5.39 billion Price / Sales0.66 Cash Flow$6.68 per share Price / Cash Flow5.14 Book Value$33.96 per share Price / Book1.01Miscellaneous Outstanding Shares103,241,000Free Float102,890,000Market Cap$3.54 billion OptionableOptionable Beta1.66 Key ExecutivesMichelle KeefeChief Executive Officer & DirectorMichael BrooksChief Operating OfficerJason Michael MeggsChief Financial OfficerLarry A PickettChief Information & Digital OfficerBaba ShettyPresident-Technology & Data SolutionsKey CompetitorsMedpaceNASDAQ:MEDPCharles River Laboratories InternationalNYSE:CRLMaravai LifeSciencesNASDAQ:MRVIiRhythm TechnologiesNASDAQ:IRTCCRISPR TherapeuticsNASDAQ:CRSPView All CompetitorsInsiders & InstitutionsMetLife Investment Management LLCSold 1,171 shares on 3/23/2023Ownership: 0.063%ETF Managers Group LLCBought 20,647 shares on 3/23/2023Ownership: 0.020%OLD Mission Capital LLCBought 842 shares on 3/6/2023Ownership: 0.001%Voya Investment Management LLCSold 8,426 shares on 2/28/2023Ownership: 0.035%Teachers Retirement System of The State of KentuckySold 12,628 shares on 2/22/2023Ownership: 0.050%View All Insider TransactionsView All Institutional Transactions SYNH Stock - Frequently Asked Questions Should I buy or sell Syneos Health stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares. View SYNH analyst ratings or view top-rated stocks. What is Syneos Health's stock price forecast for 2023? 10 equities research analysts have issued 1-year price targets for Syneos Health's stock. Their SYNH share price forecasts range from $28.00 to $81.00. On average, they anticipate the company's stock price to reach $54.00 in the next twelve months. This suggests a possible upside of 57.3% from the stock's current price. View analysts price targets for SYNH or view top-rated stocks among Wall Street analysts. How have SYNH shares performed in 2023? Syneos Health's stock was trading at $36.68 at the beginning of 2023. Since then, SYNH stock has decreased by 6.4% and is now trading at $34.33. View the best growth stocks for 2023 here. Are investors shorting Syneos Health? Syneos Health saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 3,430,000 shares, a drop of 46.6% from the February 28th total of 6,420,000 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is currently 2.1 days. Currently, 3.4% of the company's stock are sold short. View Syneos Health's Short Interest. When is Syneos Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023. View our SYNH earnings forecast. How were Syneos Health's earnings last quarter? Syneos Health, Inc. (NASDAQ:SYNH) issued its quarterly earnings results on Thursday, February, 16th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.07 by $0.08. The business earned $1.36 billion during the quarter, compared to analyst estimates of $1.29 billion. Syneos Health had a net margin of 4.94% and a trailing twelve-month return on equity of 13.19%. What ETFs hold Syneos Health's stock? ETFs with the largest weight of Syneos Health (NASDAQ:SYNH) stock in their portfolio include First Trust Health Care AlphaDEX Fund (FXH), Invesco S&P MidCap 400 Pure Value ETF (RFV), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC), First Trust Mid Cap Value AlphaDEX Fund (FNK), Syntax Stratified MidCap ETF (SMDY), Vanguard Small-Cap Growth ETF (VBK), Vanguard U.S. Value Factor (VFVA) and Humankind US Stock ETF (HKND). What guidance has Syneos Health issued on next quarter's earnings? Syneos Health updated its FY 2023 earnings guidance on Monday, February, 20th. The company provided earnings per share (EPS) guidance of $3.26-$3.53 for the period, compared to the consensus estimate of $3.89. The company issued revenue guidance of $4.97 billion-$5.17 billion, compared to the consensus revenue estimate of $5.13 billion. What is Alistair Macdonald's approval rating as Syneos Health's CEO? 322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees. What other stocks do shareholders of Syneos Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC). What is Syneos Health's stock symbol? Syneos Health trades on the NASDAQ under the ticker symbol "SYNH." Who are Syneos Health's major shareholders? Syneos Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Clearbridge Investments LLC (4.03%), Mackenzie Financial Corp (2.25%), JPMorgan Chase & Co. (2.12%), AQR Capital Management LLC (2.10%), Alliancebernstein L.P. (2.05%) and Cooke & Bieler LP (1.83%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Robert Parks, Thomas H Lee Advisors, Llc and Tom Allen. View institutional ownership trends. How do I buy shares of Syneos Health? Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Syneos Health's stock price today? One share of SYNH stock can currently be purchased for approximately $34.33. How much money does Syneos Health make? Syneos Health (NASDAQ:SYNH) has a market capitalization of $3.54 billion and generates $5.39 billion in revenue each year. The company earns $266.50 million in net income (profit) each year or $2.57 on an earnings per share basis. How many employees does Syneos Health have? The company employs 29,395 workers across the globe. How can I contact Syneos Health? Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360. This page (NASDAQ:SYNH) was last updated on 3/29/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.